Blood supply improvement

“Blood supply improvement" refers broadly to any intervention or physiological process that increases the amount of blood delivered to tissues. This can be achieved through lifestyle changes (exercise), medications that dilate vessels or reduce clotting risk, surgical interventions like angioplasty, and other means. The underlying biology involves many different molecules and pathways—including those regulating vasodilation/constriction (such as nitric oxide signaling), endothelial function, platelet activity, and more. Because it is not itself a discrete protein/receptor/enzyme/transporter/etc., it cannot be classified as a canonical drug target. In summary: “Blood supply improvement” is too broad/generic for use as the name of a molecular drug target—it describes an outcome involving many possible biological pathways rather than one actionable biomolecule.

Other names

Improved circulationEnhanced blood flowCirculatory enhancement

Not applicable to this 'target' as it is not a molecule; however, mechanisms for improving blood supply include vasodilation of vessels, reduction of blood viscosity/clot prevention, and lowering vascular resistance/arterial relaxation. These are actions on various actual targets such as nitric oxide pathway enzymes/receptors.